Skip to main content
F
Formulate
Jobs
Companies
Drugs
Advisor
NEW
Insider Intel
Salary
Pricing
Toggle theme
Toggle theme
Menu
argenx Jobs | Formulate
Jobs
argenx
argenx Jobs
Belgium - Zwijnaarde
Biotechnology
argenx is a life sciences company focused on Antibody therapies.
124
open positions at argenx
View Full Profile
Filters:
Immunology ×
Rheumatology Territory Business Manager, San Francisco, CA
argenx
Posted 1mo ago
San Francisco
$140K - $193K
Full-time
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Rheumatology Territory Business Manager, San Jose/Central, CA
argenx
Posted 1mo ago
San Jose
$140K - $193K
Full-time
Rheumatology Territory Business Manager, Los Angeles East
argenx
Posted 1mo ago
Los Angeles
$140K - $193K
Full-time
Rheumatology Territory Business Manager, Long Island, NY
argenx
Posted 1mo ago
Brooklyn
$140K - $193K
Full-time
Rheumatology Territory Business Manager, North Indiana
argenx
Posted 1mo ago
Fort Wayne; South Bend
Full-time
Rheumatology Territory Business Manager, Augusta, GA
argenx
Posted 1mo ago
Augusta
$140K - $193K
Full-time
Rheumatology Territory Business Manager, Salt Lake City, UT
argenx
Posted 1mo ago
Salt Lake CIty; Sacramento
$140K - $193K
Full-time
Rheumatology Territory Business Manager, Denver, CO
argenx
Posted 1mo ago
Denver, CO
$140K - $193K
Full-time
Rheumatology Territory Business Manager, West Palm Beach, FL
argenx
Posted 1mo ago
Sarasota; West Palm Beach
$140K - $193K
Full-time
Rheumatology Territory Business Manager, Lansing/Grand Rapids, MI
argenx
Posted 1mo ago
Grand Rapids; Lansing
$140K - $193K
Full-time
Rheumatology Territory Business Manager, San Diego, CA
argenx
Posted 1mo ago
San Diego; Irvine
$140K - $193K
Full-time
Rheumatology Territory Business Manager, Cincinnati, OH
argenx
Posted 1mo ago
Cincinnati; Louisville
Full-time
Rheumatology Territory Business Manager, Indianapolis W/Illinois
argenx
Posted 1mo ago
Indianapolis
$140K - $193K
Full-time
Rheumatology Territory Business Manager, Columbus, OH
argenx
Posted 1mo ago
Columbus; Toledo
Full-time
Rheumatology Territory Business Manager, Kansas City, MO
argenx
Posted 1mo ago
Kansas City
Full-time
Rheumatology Territory Business Manager, Little Rock-Shreveport
argenx
Posted 1mo ago
Shreveport; Little Rock
Full-time
Rheumatology Territory Business Manager, New Orleans, LA
argenx
Posted 1mo ago
New Orleans; Baton Rouge
Full-time
Rheumatology Territory Business Manager, Fort Woth, TX
argenx
Posted 1mo ago
Fort Worth
$140K - $193K
Full-time
Rheumatology Territory Business Manager, Oklahoma City, OK
argenx
Posted 1mo ago
Oklahoma City
$140K - $193K
Full-time
Rheumatology Territory Business Manager, Albuquerque, NM
argenx
Posted 1mo ago
Albuquerque; Phoenix; Tucson
$140K - $193K
Full-time
Previous
1
2
3
Company Overview
Active Jobs
171
Pipeline Programs
88
Drug Products
2
Clinical Trials
91
View Full Company Profile
Therapeutic Areas
Neurology
Immunology
Oncology
Links
Company Website
Careers Page
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
Related drug:
VYVGART
Condition in scope:
Neonatal Presentation (First 28 Days of Life)
Commercial
Immunology
MANAGER
H-1B · 1 FY23
4
5
6
7
Next
Hematology
Rare Diseases